Quick Search:         Advanced Search
Chinese Version
Online office
Journal Online
Download
Top
Links
陈汉诚,翁伦华.黄芪首乌化纤汤与金水宝胶囊抗乙型肝炎肝纤维化疗效比较[J].,2000,(4):255-257
黄芪首乌化纤汤与金水宝胶囊抗乙型肝炎肝纤维化疗效比较
Comparison on Efficacy in Treating Liver Fibrosis of Chronic Hepatitis B between Astragalus Polygonum AntiFibrosis Decoction and Jinshuibao Capsule
  
DOI:
中文关键词:  慢性乙型肝炎  肝纤维化  黄芪首乌化纤汤  金水宝胶囊
英文关键词:chronic hepatitis B  liver fibrosis  Astragalus-Polygonum Anti-Fibrosis decoction  Jinshuibao capsule
基金项目:
Author NameAffiliation
CHEN Hancheng Ningbo Municipal Liver Diseases Hospital, Zhejiang (315010 
翁伦华 Ningbo Municipal Liver Diseases Hospital, Zhejiang (315010 
Hits: 1490
Download times: 1118
中文摘要:
      观察中药复方黄芪首乌化纤汤抗慢性乙型肝炎(慢性乙肝)肝纤维化的作用,寻找抗肝纤维化有效中药复方。方法:慢性乙肝肝纤维化患者92例,随机分为黄芪首乌化纤汤治疗组47例,虫草孢子菌丝制剂金水宝胶囊对照组45例,进行为期48周的对照治疗。对照治疗前后肝纤维化4项血清学指标:透明质酸(HA)、层粘连蛋白(LN)、Ⅲ型前胶原(PCⅢ)、Ⅳ型胶原(CⅣ);肝功能主要指标:总胆红素(TB)、丙氨酸转氨酶(ALT)、白/球蛋白(A/G)比例;肝炎相关血清生化指标:甘胆酸(CG)、铁蛋白(SF)、前白蛋白(PA)。结果:治疗组HA、LN、PCⅢ及CⅣ均有明显下降,两组比较有显著性差异(P<0.01);两组治疗前后TB、ALT和肝炎相关血清生化指标CG、SF值治疗组较对照组明显下降,而A/G、PA则明显升高,两组比较有显著性差异(P<0.01)。结论:黄芪首乌化纤汤抗慢性乙肝肝纤维化比金水宝胶囊更加有效,对肝脏炎症的抑制更明显,是一种抗肝纤维化的良好复方中药制剂。
英文摘要:
      To observe the efficacy of Astragalus-Polygonum Anti-Fibrosis Decoction (APAFD) and Jin shuibao capsule (JSBC) in treating liver fibrosis of chronic hepatitis B. Methods: Ninety-two liver fibrosis of chronic hepatitis B patients were randomly divided into group A and B. Patients in group A received APAFD for 48 weeks, and in group B, they received JSBC for 48 weeks. The effects were observed on the change of hyaluronic acid (HA), laminin (LN), pro-collagen Ⅲ (PCⅢ) and collagen Ⅳ (CⅣ) as well as liver functional tests and liver biochemical parameters before and after treatment. Results: Levels of serum HA, LN, PCⅢ and CⅣ in the group A declined more obviously than that of group B, the difference was significant (P<0.01). The liver functional tests such as total bilirubin (TB), alanine aminotransferase (ALT), albumin/globulin ratio, hepatitis related serum biochemical parameters such as cholylglycine (CG), serum ferritin (SF), prealbumin (PA) of group A all were improved more significantly than that of group B (P<0. 01). Conclusion: APAFD is more effective than JSBC in treating liver fibrosis of chronic hepatitis B, and in the inhibition of hepatic inflammation, it is a good composite Chinese herbal preparation against liver fibrosis.
View Full Text  View/Add Comment  Download reader